Flagellate erythema is seen as a skin manifestation of #dermatomyositis (DM), occurring in 5% of patients. There is an association between the presence of flagellate erythema in DM and malignancy, with 38% of reported cases of DM-associated flagellate erythema having concurrent malignancies.
🔗https://t.co/A7wFYGdYZX
Check the Level of Evidence and Support for bDMARDs by axSpA Subtype from the new ASAS-EULAR Recommendations for the Management of axSpA.
See the updated slides of the management guidelines in the ASAS slide library: https://t.co/zKu8QKb6H7
#EULAR2024
New EULAR recommendations for managing systemic sclerosis (SSc) are here! Let's break down the key points for effective patient care. 🧵
RP: CCB ➡️ PDE5i➡️ IV iloprost
DU: PDE5i/ IV iloprost
DU Prevention : Bosentan
JAMA review of ILD; that affects 650,000 in USA, leading to 25,000-30,000 deaths/YR. Types reviewed. Key Symptoms: dyspnea and cough, w/ chest CT being diagnostic tool. Antifibrotic & immunomodulatory may slow disease progression. https://t.co/xegChTUysM
🔥Are you rheumatologist or allied specialist involved in the management of patients with #AxSpA?
Your expertise is invaluable! Can you spare 5 minutes to complete our survey and share your experience and insights 💡?
Thank You in advance 🙏
👉https://t.co/C33zp3yXlS
The more clinicians I talk to, the more they confirm that the belief that exercise 'wears down the knee cartilage' exists.
Well, it seems it DOES NOT harm knee cartilage.
Still a long way to go to debunk this myth!
Be part of the change ✅
#arthritis
https://t.co/GUjeomSqJP
Pleased to share our review in the @TheLancetRheum discussing current insights and future frontiers for inflammatory #myopathies. Full text and pictures accessible here! https://t.co/F3JHH5XJZM
A huge percentage of adults have a condition that seriously increases their risk of heart disease.
The problem is.... most don't even know they have it.
📕Make Sure To Bookmark✅
🧵👇
/1
Thanks Makoto Miyara for your great update on autoantibodies at our @CRMR_RESO winterschool. I'm reposting my slide ⬇️ on the same topic, so that more people can get/use it 👍 #lupus
New content online! International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative https://t.co/cN32vS0cEm
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
🔴 HCQ for all 5 mg/kg/day
🔴 GC as ‘bridging therapy’ or maintenance ≤ 5 mg/day
🔴 Prompt initiation of immunosuppressive and/or biological agents
@eular_org
👉 https://t.co/5EWz7QXaHd
✅ How does #hydroxychloroquine work? What are its main mechanisms of action in #Lupus? There are so many beneficial effects in #SLE 👍 Check our extensive review ⬇️ for more details 🔎 #TLR#autophagy
📥 FREE Download Link: https://t.co/I6DDdLJA5M
✅ Lot's of interest about #retina toxicity of #hydroxychloroquine in #lupus so let's check the actual numbers ⬇️ which remain very low, including in patients receiving #HCQ at doses >5mg/kg/day
Excellent #SLICC paper from the group of S. Bernatsky 👍
https://t.co/UQ0QtxBb66
The Consultants of Dorset hospital have written a letter to @SteveBarclay
They strike tomorrow
This letter is incredible
I challenge anyone to refute a single point in it
Worth a read for you too @wesstreeting
#EULAR2023
Another brilliant talk from @Lupusreference about relapsing polychondritis
🔺How to recognize RP
🔺Differential diagnosis with VEXAS-RP
🔺Treatment:
✅GC for minor/ colchicine/ MTX/ dapsone
✅CYC or biologics for severe or refractory
🔺RPDAI/RPDAM as activity tools